Sigma Planning Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
2,280
-34
| -1% | -$15.1K | 0.03% | 496 |
|
|
2025
Q1 | $1.12M | Sell |
2,314
-17
| -0.7% | -$8.24K | 0.04% | 457 |
|
|
2024
Q4 | $939K | Sell |
2,331
-415
| -15% | -$167K | 0.03% | 510 |
|
|
2024
Q3 | $1.28M | Sell |
2,746
-261
| -9% | -$121K | 0.04% | 416 |
|
|
2024
Q2 | $1.41M | Buy |
3,007
+14
| +0.5% | +$6.56K | 0.04% | 375 |
|
|
2024
Q1 | $1.25M | Buy |
2,993
+1,212
| +68% | +$507K | 0.04% | 436 |
|
|
2023
Q4 | $724K | Sell |
1,781
-1,061
| -37% | -$432K | 0.06% | 339 |
|
|
2023
Q3 | $988K | Buy |
2,842
+80
| +3% | +$27.8K | 0.04% | 471 |
|
|
2023
Q2 | $972K | Buy |
2,762
+10
| +0.4% | +$3.52K | 0.03% | 464 |
|
|
2023
Q1 | $867K | Sell |
2,752
-412
| -13% | -$130K | 0.03% | 569 |
|
|
2022
Q4 | $914K | Buy |
3,164
+44
| +1% | +$12.7K | 0.03% | 519 |
|
|
2022
Q3 | $903K | Buy |
3,120
+1,082
| +53% | +$313K | 0.03% | 492 |
|
|
2022
Q2 | $574K | Buy |
2,038
+535
| +36% | +$151K | 0.02% | 697 |
|
|
2022
Q1 | $392K | Sell |
1,503
-112
| -7% | -$29.2K | 0.01% | 935 |
|
|
2021
Q4 | $355K | Sell |
1,615
-1,193
| -42% | -$262K | 0.01% | 988 |
|
|
2021
Q3 | $509K | Buy |
2,808
+1,201
| +75% | +$218K | 0.02% | 799 |
|
|
2021
Q2 | $324K | Buy |
1,607
+390
| +32% | +$78.6K | 0.01% | 1025 |
|
|
2021
Q1 | $262K | Buy |
1,217
+22
| +2% | +$4.74K | 0.01% | 1044 |
|
|
2020
Q4 | $282K | Buy |
+1,195
| New | +$282K | 0.01% | 919 |
|
|
2020
Q3 | – | Sell |
-9,006
| Closed | -$2.62M | – | 1153 |
|
|
2020
Q2 | $2.62M | Buy |
+9,006
| New | +$2.62M | 0.11% | 183 |
|
|
2020
Q1 | – | Sell |
-1,104
| Closed | -$242K | – | 1099 |
|
|
2019
Q4 | $242K | Buy |
+1,104
| New | +$242K | 0.01% | 881 |
|
|
2015
Q1 | – | Sell |
-8,483
| Closed | -$1.01M | – | 790 |
|
|
2014
Q4 | $1.01M | Buy |
+8,483
| New | +$1.01M | 0.13% | 181 |
|